A new study details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery — thanks to an antibody initially developed for rheumatoid arthritis.
A new study details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery — thanks to an antibody initially developed for rheumatoid arthritis.